Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heyan Kuntai Capsule after hysterectomy in perimenopausal women
ChiCTR2000029019Phase 4Not yet recruiting
- Sponsor
- Changzhou Second People's Hospital
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 4, open-label trial of Kuntai in ovarian hypofunction (POI) (2 arms), sponsored by Changzhou Second People's Hospital. Primary endpoints: Follicle-stimulating hormone, Kupperman score and 1 more. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
Kuntai
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on ChiCTR2000029019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029019.